ALHC Investor Notification: Alignment Healthcare Investigated for Securities Fraud on behalf of Investors with Losses after Inflated EBITDA Leads to 16% Stock Drop
BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost executive compensation. NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Leading securities law...
Covered in this story
Analyst targets on Alignment Healthcare Inc
- UBS: at $8.09 · target $9 by Oct 2027 · Neutral via Investing.com
- TD Cowen: at $8.14 · target $12 by Oct 2027 · Buy via Investing.com
- Bank of America: at $7.54 · target $9 by Oct 2027 · Neutral via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ALHC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alignment Healthcare Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.